ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer

Wei, Zhentong; Liu, Yan; Wang, Yishu; Zhang, Yandong; Luo, Qinghua; Man, Xiaxia; Wei, Feng*; Yu, Xiaowei*吉林大学; 中国人民解放军军事医学科学院; 1
MEDICAL ONCOLOGY2016-11DOI: 10.1007/s12032-016-0842-9
38被引3阅读
引用收藏
分享

摘要

Ovarian cancer (OVCa) stem cells are associated with tumor growth, metastasis, and recurrence, which are driving forces behind a majority of the OVCa-related mortality. This subpopulation of cancer cells are characterized by uncontrolled proliferation, high invasiveness, and resistance against the current platinum-based therapy. Thus, targeting OVCa cancer stem cells has been focused in recent therapeutic development. Isolation and purification of cancer stem cells are, however, challenging for the lack of sensitive and specific markers. In this study, we demonstrated that miR-551b was upregulated in OVCa stem cells, by using a quantitative PCR array, correlating with the pathological grades of this malignancy. In vitro experiments indicated that miR-551b promoted the proliferation, invasion, and chemoresistance of OVCa cells and cancer stem cells. Further analysis suggested that miR-551b functioned through the suppression of Foxo3 and TRIM31, two important tumor suppressors. In support of this, our in vivo experiments using mouse xenograft models showed that inhibiting miR-551b significantly increased the susceptibility of OVCa cells to cisplatin and prolonged the survival of the host mice. In conclusion, our study suggested miR-551b as a potential biomarker for OVCa stem cells and explored its functional mechanism, providing a potential therapeutic target for future drug development.

学科与关键词

关键词
Ovarian cancerSide population of cancer cellsmiR-551bCell proliferationCell invasionDrug resistance
相关
加载中…
  • Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway
    Jia, Yiming; Li, Jingru; Wang, Jinfeng; Luo, Tianjiao; Jing, Xiaoqian; Zhao, Hongmin*Analytical Cellular Pathology-Cellular Oncology, 2022, 2022: 1732365.
  • microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1α expression
    Peng, Dongxian; Wu, Tingting; Wang, Junxia; Huang, Jie; Zheng, Lijiao; Wang, Pingping; Li, Junpeng; Wu, Lin; Luo, Min*Chemico-Biological Interactions, 2022, 355: 109780.被引 9
  • Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis
    Li, Bing*; Lou, Ge; Zhang, Jiahui; Cao, Ning; Yu, XiBMC CANCER, 2022, 22(1): 124.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
MEDICAL ONCOLOGY
发表日期
2016-11
卷期
第 33 卷, 第 11 期
页码
126
DOI
10.1007/s12032-016-0842-9
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301884]; Jilin Province Science and Technology Development Program [20140520032JH, 20140520036JH, 20160414052GH]; Jilin UniversityJilin University [450060521279]

作者

  • W

    Wei, Zhentong (第一作者)

    1 · jilin univ

  • L

    Liu, Yan

    1 · jilin univ

查看全部 8 位作者收起作者
  • W

    Wang, Yishu

    jilin univ

  • Z

    Zhang, Yandong

    1 · jilin univ

  • L

    Luo, Qinghua

    1 · jilin univ

  • M

    Man, Xiaxia

    1 · jilin univ

  • W

    Wei, Feng (通讯)

    acad mil med sci

  • Y

    Yu, Xiaowei (通讯)

    jilin univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417